Login / Signup
Zhi-Gang Sun
(Zhigang Sun)
ORCID
Publication Activity (10 Years)
Years Active: 2021-2024
Publications (10 Years): 5
Top Topics
Squamous Cell
Oxide Nanoparticles
Poor Prognosis
Transcription Factor
Top Venues
Cancer management and research
OncoTargets and therapy
Disease markers
Cancer cell international
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Yepeng Wang
,
Chao Ma
,
Xuekun Yang
,
Jun Gao
,
Zhi-Gang Sun
ZNF217: An Oncogenic Transcription Factor and Potential Therapeutic Target for Multiple Human Cancers.
Cancer management and research
16 (2024)
Yepeng Wang
,
Chao Ma
,
Xuekun Yang
,
Jun Gao
,
Zhi-Gang Sun
ZNF217: An Oncogenic Transcription Factor and Potential Therapeutic Target for Multiple Human Cancers.
Cancer management and research
16 (2024)
Chao Ma
,
Rui-Jie Ma
,
Kang Hu
,
Qi-Ming Zheng
,
Ye-Peng Wang
,
Nan Zhang
,
Zhi-Gang Sun
The molecular mechanism of METTL3 promoting the malignant progression of lung cancer.
Cancer cell international
22 (1) (2022)
Rui-Jie Ma
,
Qi-Ming Zheng
,
Nan Zhang
,
Zhi-Gang Sun
Clinicopathological Significance of STAT3 and p-STAT3 among 91 Patients with Adenocarcinoma of the Esophagogastric Junction.
Disease markers
2022 (2022)
Qing-Kang Zheng
,
Chao Ma
,
Irfan Ullah
,
Kang Hu
,
Rui-Jie Ma
,
Nan Zhang
,
Zhi-Gang Sun
Roles of N6-Methyladenosine Demethylase FTO in Malignant Tumors Progression.
OncoTargets and therapy
14 (2021)